Objective. JIA is an autoimmune, inflammatory disease with involvement of innate and adaptive immune responses. However, the role of neutrophils in JIA pathogenesis remains unclear. This study aimed to identify and validate neutrophil gene expression signatures in JIA using public microarray datasets and new clinical samples.
Introduction
JIA is a leading cause of rheumatic disease in childhood, encompassing a heterogeneous group of conditions characterized by joint inflammation of unknown origin persisting for a period of > 6 weeks [1, 2] . Presentation occurs in early childhood before the age of 16 years. JIA has been reported as one of the leading causes of both long-and short-term disability among children, affecting $10 in every 100 000 children [1, 2] . The ILAR classifies JIA into a number of clinical subtypes, including polyarticular (pJIA), oligoarticular (oJIA), systemic (sJIA), enthesitisrelated JIA, psoriatic JIA and undifferentiated arthritis [3, 4] . Both pJIA and oJIA are the predominant forms, accounting for more than half of presenting cases within the UK [5] . While all subtypes of JIA tend to present with a clinical manifestation of localized inflammation in the joints, sJIA is also characterized by a range of extraarticular features, including fever, rash and hepatosplenomegaly, many of which have been associated with growth disorders leading to disability among patients [6] . sJIA is considered a more acute and severe subtype of JIA and it is estimated that $10% of individuals suffering from sJIA progress to macrophage activation syndrome, which can be fatal [7] .
The presence of CD4 + T lymphocytes showing a CD45RO + phenotype in inflamed synovium [8] combined with the association of HLA variants to disease risk of JIA [9] strongly supports the adaptive immune response in the pathogenesis of JIA [1012] . The role of the innate immune system, and in particular neutrophils, in JIA pathogenesis is less clear despite the fact that neutrophils are found at high concentrations in JIA SF [5, 13, 14] . Activated neutrophils play a key role in the pathogenesis of adult and juvenile autoimmune inflammatory diseases [including RA and juvenile-onset SLE (JSLE)] via their ability to release reactive oxygen species (ROS), proteases and cytokines, driving the inflammatory process and causing damage to host tissues [1517] . Neutrophils are the most abundant cells within JIA SFs, and neutrophilderived proteases and cytokines, including MPO, neutrophil elastase (NE for protein and ELANE for transcript), MMPs and IL-8, have been found at high concentrations at sites of inflammation in adult inflammatory arthritis [1820] . In adult RA, the release of MMP8, MMP9 and NE from neutrophils at the pannuscartilage interface can cause degradation of the collagen matrix [18, 19] . In sJIA, levels of neutrophil-derived calgranulins S100A8/9 and S100A12 serve as serum biomarkers for the diagnosis of JIA and correlate with disease activity [21] . pJIA neutrophils demonstrate disruption of gene regulatory networks in clusters of genes modulated by IL-8 and IFN-g [14] , with pJIA neutrophils remaining in an activated state even during periods of disease quiescence [14] . This study hypothesized that neutrophil gene expression signatures would be significantly different between JIA patients compared with healthy paediatric controls and that different gene expression profiles may be apparent across JIA subtypes. The aim of this study was to identify neutrophil gene expression signatures from public microarray datasets and to then validate these gene expression profiles in a new cohort of JIA patients. Here we report identification of neutrophil activation signatures in JIA peripheral blood. These include expression of neutrophil granule protein genes in peripheral blood mononuclear cells (PBMCs), elevated numbers of low-density granulocytes (LDGs) in peripheral blood and increased expression of granule protein genes, IL-8 and FcR1B in JIA neutrophils.
Methods

Study population
The study was approved by the North WestLiverpool East Research Ethics Committee. The study formed part of the UK JSLE Cohort Study and Repository (REC: 6/Q1502/77) and written informed patient/parental assent/consent was obtained in accordance with the Declaration of Helsinki. All JIA and healthy control (HC) patients were recruited in the study at Alder Hey Children's National Health Service Foundation Trust in Liverpool from either outpatient clinics or inpatient wards. JIA patients fulfilled the validated criteria endorsed by the ILAR before the age of 17 years [3] . Standard clinical data to determine disease activity/current disease state were collected for each of the JIA patients. Paediatric HCs had no personal or direct family history of rheumatic or chronic inflammatory disease or acute or recent history of infection. Clinical demographics for each patient cohort are detailed in supplementary Table S1 , available at Rheumatology Online. Due to the limited volumes of blood available from paediatric patients, we were unable to use the same patient samples for each set of experiments and thus the number of patients analysed within JIA subtypes differs for some experiments.
Identifying datasets from public repositories Suitable microarray datasets were selected from public repositories: NCBI Gene Expression Omnibus (GEO) database and EMBL-EBI Array Express. Key phrases such as JIA and children were used when performing searches identifying 20 relevant datasets in GEO and 17 in Array Express. Of these, datasets that had no data on sJIA or duplicate datasets between GEO and Array Express, as well as those that had patients currently on treatment, were manually eliminated, providing two datasets that could be utilized: E-GEOD-13501 [22] and GSE21521 [23] . However, we noted that the samples for both datasets came from PBMCs and, due to uncertainty about whether a neutrophil signature would be found in PBMCs, an additional dataset that contained samples that were collected from whole blood was also added to the list, GSE55319 [24] , providing an overall total of three datasets (supplementary Table S2 , available at Rheumatology Online).
Analysis of microarray datasets
Significance analysis of microarrays (SAM) was carried out on the datasets using MultiExperiment Viewer (MeV) version 4 [25] to identify any significantly different gene expression (false discovery rate adjusted P < 0.05). Hierarchical cluster analysis was performed in MeV using Euclidean clustering and average linkage.
Bioinformatics analysis
Bioinformatics analysis of differentially expressed genes (DEGs) was carried out using Ingenuity pathway analysis (IPA). All significant DEGs from each dataset that could be associated with a canonical pathway within the Ingenuity knowledge base were analysed, as previously described [26, 27] .
ELISA
Archived serum samples from 24 JIA patients (sJIA, n = 12; pJIA, n = 12) and 12 paediatric HCs were analysed by ELISA and age-and sex-matched where possible. Autoantibodies (which may interfere with ELISA antibodies and cause false-positive results) were removed by incubating sera in a 96-well plate coated with protein L for 60 min (Thermo Fisher Scientific, Paisley, UK) prior to assay [28] . The concentration of each of the proteases was determined using commercially available ELISA kits (purchased from R&D Systems, Abingdon, UK unless otherwise stated) and protocols provided by the manufacturer: NE (PMN Elastase Human ELISA kit, Abcam, Cambridge, UK), MPO, MMP8 and MMP9. The serum concentrations of each of the detected proteins were calculated with reference to the standard curve and expressed as nanograms per millilitre.
Cell preparation
Fresh samples of heparinized blood were used to isolate neutrophils (purity >95%). Briefly, at room temperature, whole blood was mixed for 30 min with HetaSep (Stemcell, Cambridge, UK) at a 5:1 ratio in order to sediment red blood cells. The resulting leucocyte-rich buffy coat was removed and layered onto Histopaque (Sigma, Gillingham, UK) and centrifuged at 800 g for 20 min. Separated neutrophils and PBMCs were washed and resuspended in Roswell Park Memorial Institute (RPMI) media. Any contaminating erythrocytes within the neutrophil pellet were removed using hypotonic lysis and cells were resuspended in RPMI media (Life Technologies, Paisley, UK). An aliquot of neutrophils and PBMCs were centrifuged at 500 g for 5 min onto a microscope slide (cytospin) to which Romansky staining (TCS Biosciences, Botolph Claydon, UK) was applied, enabling confirmation of purity and morphology under a light microscope. Isolated neutrophils and PBMCs were analysed by flow cytometry (Beckman Coulter FC500 MPL) to determine cell purity and the presence of LDGs within the PBMC population. A total of 10 000 events were analysed.
RNA extraction and quantitative PCR (qPCR)
RNA was extracted from freshly isolated neutrophils from 15 JIA (sJIA, n = 2; pJIA, n = 7; oJIA, n = 4; other JIA, n = 2) and 10 HC patients and PBMCs from 6 JIA (sJIA, n = 3; pJIA, n = 1; other JIA, n = 2) and 4 HC patients using Trizol:chloroform precipitation (Life Technologies, Paisley, UK), followed by clean-up using the RNeasy Mini Kit, which included a DNase digestion step (Qiagen, Manchester, UK). RNA from each sample was reverse transcribed into cDNA using the Affinity Script cDNA Synthesis kit (Agilent Technologies, Cheshire, UK). qPCR was performed using the Brilliant ultra-fast SYBR green qPCR mastermix (Agilent Technologies, Cheshire, UK) and validated primers (supplementary Table S3 , available at Rheumatology Online) for candidate genes: MPO, MMP8, MMP9, ELANE, IL8 and FCGR1B as well the housekeeping gene b-actin (ACTB). A one in ten dilution was used on all DNA samples. PCRs took place in the MX3005P Stratagene Multiplex Quantitative qPCR system using standard thermal cycling conditions as follows: 95 C for 3 min for 1 cycle, followed by 95 C for 20 s and 60 C for 20s for 40 cycles. The detection of the SYBR green was calculated and a dissociation curve was obtained. All mRNA expression values for candidate genes were normalized to that of the housekeeping gene [29] using the ÁÁC t method [30] .
Statistical analysis
Statistical analysis was carried out using GraphPad Prism (version 4; GraphPad Software, La Jolla, CA, USA).
Patient and control data were tested for normality using the KolmogarovSmirnov test. For data comparing multiple groups, the KruskalWallis test was performed and the MannWhitney test was used when testing only two groups. Data were considered statistically significant for P < 0.05.
Results
Identification of neutrophil gene expression signatures in JIA microarray datasets SAM was carried out on each of the datasets using MeV identifying significantly different gene expression (DEG; q < 0.05) between groups, that is, sJIA vs HCs, pJIA vs HCs, sJIA vs pJIA. The number of DEG up-and downregulated in each dataset is shown in Table 1 .
Using IPA, we carried out bioinformatics analysis of DEG from each dataset to identify signalling pathways with different regulation in JIA (Fig. 1A) . The significant pathways that were identified as elevated in JIA included cytokine signalling pathways (IL-8, GM-CSF, TGF-b), kinase pathways (JAK/STAT, STAT3, PI3K/AKT, NF-kB), pathways relating to cell migration (actin cytoskeleton, leucocyte extravasation, integrins), pathways relating to production of ROS (production of NO and ROS, phospholipase C) and regulation of cell cycle checkpoints. Upstream regulator analysis was also performed; this is an algorithm used by IPA that examines how many known targets of a transcription regulator (e.g. cytokine or transcription factor) are present in the dataset and compares the direction of change to what is expected from the literature in order to predict likely relevant transcriptional regulators. In all datasets, G-CSF/CSF3 was predicted to be regulating the global gene expression signature in JIA compared with HCs (supplementary Table S4 , available at Rheumatology Online).
Network analysis was then conducted to identify the relationships between G-CSF and the genes in each dataset. The network of G-CSF-regulated genes included several genes coding for neutrophil granule protein genes, including MPO, MMP8, MMP9 (Fig. 1B) . Further analysis revealed high levels of expression of a number of neutrophil protease genes in sJIA patients from two of the datasets (GSE21521 and E-GEOD-13501) as shown in Fig. 1C and Table 2 . The identification of neutrophil protease genes in sJIA PBMC microarray datasets was unexpected, as neutrophils isolated by density gradient separation do not remain within the PBMC fraction. We hypothesized that the gene signature observed was due to the presence of LDGs in the PBMC datasets. LDGs have been described in adult and JSLE, as well as RA, as a distinct subset of neutrophils with an altered phenotype [3133] .
Identification of LDGs in the PBMC fraction of JIA blood
To determine the presence of LDGs in JIA PBMCs, we collected samples from 16 patients with JIA (subtypes sJIA, n = 6; pJIA, n = 3; oJIA, n = 3; other JIA, n = 4; of which 6 were on biologics and 2 on steroids; see supplementary Table S1 , available at Rheumatology Online) and 19 HC patients. Cells were analysed by flow cytometry based on forward/side-scatter properties and those falling within the neutrophil gate were considered LDGs. Cytospins were prepared to confirm the presence of cells with neutrophil morphology within PBMC fractions of JIA blood (Fig. 2A) . The number of LDGs was significantly elevated in JIA PBMCs {median n = 16, 1. Fig. 2B ; P = 0.007). The LDG percentage was compared with patient ESR, neutrophil count and disease duration; no correlation was observed (data not shown).
Measurement of neutrophil proteases in JIA sera
Transcripts for neutrophil granule proteins including ELANE, MPO, MMP8 and MMP9 were significantly elevated in public datasets for sJIA PBMCs. We therefore measured the level of neutrophil proteases present in the sera of JIA patients (sJIA, n = 12; pJIA, n = 12; of which 13 were on biologics, 6 on DMARDs and 12 on steroids; see supplementary Table S1 , available at Rheumatology Online) compared with age-and sexmatched paediatric HCs. There was no significant difference between the study groups (sJIA, pJIA, HCs) in serum concentrations of NE (P = 0.318), MMP8 (P = 0.7) and MPO (P = 0.6) (Fig. 3) . However, the levels of MMP9 were significantly different by analysis of variance between the three study groups (P = 0.013; Fig. 3 ). Post hoc analysis revealed that MMP9 was significantly lower in sJIA patients [median 93.38 ng/ml (IQR 41.37209. 
Gene expression in JIA neutrophils
To test the hypothesis that genes for MPO, MMP8, MMP9 and ELANE are more highly expressed in JIA compared with HC neutrophils, we isolated mRNA from 15 JIA (subtypes sJIA, n = 2; pJIA, n = 7; oJIA, n = 4; other JIA, n = 2; of which 12 were on biologics and 1 on DMARDS; see supplementary with HCs [0.03 (IQR 0.020.05)], this did not reach statistical significance (P = 0.1; Fig. 4A ). We also investigated the expression levels of IL-8 and FCGR1B. The IL-8 and GM-CSF signalling pathway, which activates expression of IL-8 in neutrophils [26] , were identified by IPA Õ as being elevated in JIA. FCGR1B was chosen because it was identified in all datasets as having significantly higher expression and is 
Discussion
In this study we analysed three publically available datasets to identify neutrophil gene expression signatures activated in JIA. We identified the expression of neutrophil protease genes, including ELANE, MPO, MMP8 and MMP9 in sJIA PBMCs, which indicates the presence of LDGs. While LDGs only represent a small percentage of the total PBMC population, work by ourselves and others [31, 33] has shown that the expression level of many neutrophil granule protein genes is many times higher in LDGs compared with mature neutrophils [33] . Similar large increases in expression of neutrophil granule protein genes, including elastase and MPO, have been reported in JIA PBMCs and attributed to an innate immune signature [34] . We confirmed the presence of LDGs in JIA by analysing samples from a new cohort of JIA patients. LDGs have been described in other rheumatic conditions, including SLE and JSLE [31, 32] and RA [33] . These studies have explored LDG functional capacity and their potential to contribute to clinical manifestations. In adult SLE, LDGs contribute to heightened pro-inflammatory responses and production of IFN-a via increased neutrophil extracellular trap production [31] . In JSLE, the numbers of LDGs correlate with disease activity and titres of dsDNA antibodies [32] . In RA, LDGs are less responsive to TNF-a and represent a more immature neutrophil phenotype [33] . LDGs have also been reported to play a critical role in the pathology of other adult inflammatory diseases, including vasculitis and asthma [35, 36] . The presence of LDGs in JIA raises the possibility that these cells contribute to the pathophysiology of the disease. However, while we have confirmed the presence of LDGs in JIA peripheral blood, the functional phenotype of these cells in JIA remains to be explored.
Neutrophils release serine proteases, including NE, MMP8 and MMP9, when inappropriately activated during inflammation. MMPs, a superfamily of proteases, engage in physiological tissue development as well as tissue destruction [37] . By processing pro-forms of cytokines and chemokines they are able to mediate both proand anti-inflammatory processes. In addition, MMP9 degrades a1-antiproteinase, a potent elastase inhibitor, perpetuating the inflammatory response [37] . Regulated by tissue inhibitors of MMPs, enzymes MMP8 and MMP9 are released by neutrophils following migration to the site of inflammation. Observations have shown an imbalance between tissue inhibitors of MMPs and MMP8/9 leads to pathological tissue destruction. Indeed, both MMP8 and MMP9 are found at high concentrations in the SF of adult patients with RA [38, 39] . Both MMP8 and MMP9 cleave components of the collagen matrix within the joint, including collagens V, VII and X, aggrecan and fibronectin [40] . Surprisingly, we found that levels of neutrophil proteases in the sera of sJIA and pJIA patients were not elevated compared with HCs. Moreover, MMP9 levels were significantly lower in JIA patients compared with HCs and were significantly lower in sJIA compared with pJIA. There may be several explanations for this observation. First, the ELISAs used in our study measured the concentration of the proteases in serum but did not measure enzyme activity. Second, while there is evidence for elevated protease levels at the site of inflammation (synovial joints) in adult RA [18, 38, 39] , it is unclear whether these proteases are elevated in sera. Third, the results may be explained by the heterogeneous nature of JIA subtypes. Finally, all JIA patients in our study were receiving medication, with many receiving biologic PBMCs: E-GEOD-13501, GSE21521; whole blood: GSE55139. Data shown as log 2 (fold change). P > 5.00E-2 are considered not significant (NS).
and/or disease-modifying therapies and, as such, this places limitations on the interpretation of our data. Studies have determined that levels of neutrophil-derived proteases can be affected by anti-inflammatory therapies.
A longitudinal study showed lower levels of MMP9 in a subset of pJIA patients following a year of treatment with the TNF inhibitor etanercept [41] . The blockade of cytokine and chemokine synthesis in both peripheral blood cells and synovial tissue caused by TNF inhibitor therapy leads to lower levels of serum proteases [41, 42] . Similarly, tocilizumab, a humanized monoclonal IL-6 receptor (IL-6R) antibody used in the treatment of sJIA, indirectly decreases levels of MMP9 [43] . The use of drugs such as MTX in other inflammatory conditions such as RA has been reported to reduce levels of cytokines such as IL-8 in the serum [44, 45] . Unfortunately, it is not possible to comment on the effect of treatment on LDG expression in our study due to the small sample size; only one of the patients was not on medication and the majority were receiving biologics.
The level of expression of genes for neutrophil granule proteins ELANE, MPO, MMP8 and MMP9 was higher in neutrophils from all JIA subtypes compared with HCs, although the levels differed across the JIA patient cohort due to the heterogeneous nature of this condition. This observation could be partially explained by suppressed immune activity during therapy. However, a recent study found that gene expression in JIA neutrophils remains in a state of activation despite response to treatment [46] . Mature adult neutrophils do not normally express transcripts for neutrophil granule proteins; expression of genes such as MPO and ELANE are downregulated during terminal differentiation of neutrophils prior to release from the bone marrow [47] . However, expression of neutrophil granule protein genes including MPO and ELANE by mature neutrophils has recently been reported in a population of RA patients and is associated with a lack of response of RA patients to TNF inhibitor therapy [48] . Elevated transcripts for ELANE, MPO, MMP8 and MMP9 were identified in public datasets from sJIA PBMCs, and while this indicates the expression of these genes by LDGs within the PBMC fraction, it gives no information on whether these genes are elevated in JIA neutrophils.
CD64 is an IFN-g-regulated Fcg receptor subclass encoded by three genes (FCGR1A, FCGR1B, FCGR1C) [49, 50] . Neutrophil FCGR1A binds monomeric IgG and is classed as a high-affinity IgG receptor. While FCGR1B and FCGR1C are commonly believed to be pseudogenes [51] lacking the extracellular immunoglobulin-like domain coded by exon 3 [52] , a splice variant of FCGR1B has been shown to bind aggregated immune complexes formed by IgG [53] . A possible role for a secreted soluble FcgR1b receptor splice variant has also been proposed [52] . Transcripts for FCGR1A were elevated in all public datasets analysed in this study, but not validated by qPCR. Increased expression of the FCGR1B transcript of CD64 by JIA neutrophils has not been previously described and is reported here for the first time. In adult RA, CD64 is expressed in high amounts in neutrophils aspirated from synovial joints and expression can be induced in HC neutrophils by the addition of IFN-g or cell-free RA SF [54] . Neutrophils expressing the CD64 receptor can be activated by monomeric IgG to produce a respiratory burst (ROS), implicated in damage to host tissue in inflammatory diseases such as RA and chronic obstructive pulmonary disease [15, 16, 50] . Expression of FCGR1B by neutrophils in JIA could therefore provide insight into the disease pathology, particularly in those pJIA patients who are RF positive. Of note, FCGR1B expression was higher in the pJIA patients when we analysed the dataset by JIA subtype. However, further investigation of CD64 protein expression is required to confirm the role of FCGR1B in the pathology of JIA.
In summary, we describe here for the first time a neutrophil activation signature in JIA patients that is due in part to the presence of elevated numbers of LDGs. Neutrophils from JIA patients have elevated transcription of genes encoding granule proteins, including MMP8, MMP9 and MPO, as well as IL-8 and the high-affinity IgG receptor CD64. This activation signature has important potential implications for disease pathology in JIA, as the release of proteases and reactive oxygen metabolites (in response to activation of FcgRs) is a major cause of systemic inflammation and damage to joints.
FIG. 3 Levels of neutrophil granule proteins in JIA and HC sera
Levels of NE, MPO, MMP8 and MMP9 were measured in serum samples from age-/sex-matched patients with sJIA, pJIA and HCs (n = 12 in each group). MMP9 levels were significantly lower in sJIA compared with HCs (**P = 0.007). Bars represent median (IQR).
